Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
Stanford University
Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification
International Center for Ethnobotanical Education, Research, and Service
Personality and Drug Use
Psychedelic Data Society
Trifecta Research Study
Johns Hopkins University
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
University of California, Irvine
Personality and Drug Use (PDU)
Quantified Citizen Technologies Inc.
Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial
University of Sao Paulo
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.